About this trial
In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve early detection for smokers will be assessed. This target population consults late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative incentive strategy for screening among general practitioners based on unusual information vectors (tobacconist, local media).
The main objective of this study is a screening of oral cavity cancers in tobacco users aged 30-75 years in the Somme region of France.
Eligibility criteria
Qualifiers
Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop located on the territory of the Somme
lives in somme departement
Disqualifiers
None
Trial design
Treatments tested in this trial
- Invitation for oral cavity cancer screening
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Picardy - Regional health agency (ARS)
Collaborator
Regional Council Picardie
Collaborator
Regional Observatory of Health and Social Issues in Picardie (OR2S)
Collaborator
Association for the screening of diseases in Somme (Adema 80)
Collaborator
Somme Cancer Registry
Collaborator